Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 3 amino 1 morpholine 4 (2,4,5 trifluorophenyl) 1 butanone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.